Abstract | BACKGROUND: AIMS: This nationwide cohort evaluated the long-term outcome of transcatheter-closed ASDs. METHODS: The study enrolled every transcatheter ASD closure performed in Finland from 1999 to 2019. Five age, sex, and municipality-matched controls per ASD patient were gathered from the general population. The median follow-up period was 5.9 years (range 0-20.8). We used the hospital discharge register to gather all hospital visits and diagnoses. Closure complications and echocardiographic changes were collected from the electronic health records. RESULTS: Transcatheter ASD closure was performed in 1000 patients (68.5% females) during the study period. The median (range) age at the time of the procedure was 37.9 (1.8-87.5) years. ASD patients had an increased risk for new-onset atrial fibrillation (RR 2.45, 95% CI: 1.84-3.25), migraine (RR 3.61, 95% CI: 2.54-5.14), ischemic heart disease (RR 1.73, 95% CI: 1.23-2.45), ventricular fibrillation/ tachycardia (RR 3.54 (95% CI: 1.48-8.43) and AV conduction disorder (RR 3.60, 95% CI: 1.94-6.70) compared to the control cohort. Stroke risk was not increased (RR 1.36, 95% CI: 0.91-2.03). Adverse events occurred in 6.3% (n = 63) of the patients, including four erosions and ten device embolizations. CONCLUSION:
|
Authors | V Muroke, M Jalanko, J Haukka, J Hartikainen, A Tahvanainen, H Ukkonen, K Ylitalo, J Pihkala, J Sinisalo |
Journal | Annals of medicine
(Ann Med)
Vol. 55
Issue 1
Pg. 615-623
(12 2023)
ISSN: 1365-2060 [Electronic] England |
PMID | 36786506
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Female
- Humans
- Adult
- Middle Aged
- Aged
- Aged, 80 and over
- Male
- Cardiac Catheterization
(adverse effects, methods)
- Atrial Fibrillation
(epidemiology, etiology)
- Treatment Outcome
- Ventricular Fibrillation
(etiology)
- Heart Septal Defects, Atrial
(epidemiology, surgery, etiology)
- Retrospective Studies
|